Pieter Janssen

Pieter Janssen possesses extensive experience in product development and medical device innovation, currently serving as the Head of Product Development at BetaGlue Therapeutics. Previous roles include Medical Device development and R&D incentive consultant at Palatine, Chief Technology Officer, Regulatory Affairs Manager, and Quality Affairs at VIPUN Medical, and Innovation Mandate holder at KU Leuven. Additionally, Pieter Janssen has worked as an Independent R&D & Innovation Consultant at Leyton. Educated at Ghent University, Pieter Janssen earned a PhD in Medical Sciences with a focus on Pharmacology, and at the University of Antwerp, completed a Master’s degree in Medical Biochemistry.